KALA BIO, Inc. IPO

Completed

KALA BIO, Inc. completed its initial public offering on NASDAQ on July 20, 2017, pricing at $15.00 a share.

Ticker	KALA
Exchange	NASDAQ
Status	Completed
Listing date	July 20, 2017
Offering price	$15.00
Shares offered	6,000,000
Total raised	$90M

The offering

KALA BIO, Inc. sold 6,000,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $90 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $90 million total recorded for the deal.

Company coverage

KALA BIO, Inc. — quote, profile and latest news →

Other recent IPOs

First Breach, Inc. · August 12, 2026
Advasa Holdings, Inc. · August 11, 2026
Latigo Biotherapeutics, Inc. · August 4, 2026
BOA Acquisition Corp. II · August 3, 2026
Obsidian Therapeutics, Inc. · August 3, 2026
Attovia Therapeutics, Inc. · July 29, 2026
Game Your Game Inc. · July 27, 2026
Scribe Therapeutics, Inc. · July 21, 2026

Source: SEC EDGAR filings for KALA BIO, Inc.. This page is general information, not investment advice.